Hemolytic anemia after mitral valve repair: a case report by Catarina Cardoso et al.
Cardoso et al. BMC Research Notes 2013, 6:165
http://www.biomedcentral.com/1756-0500/6/165CASE REPORT Open AccessHemolytic anemia after mitral valve repair: a case
report
Catarina Cardoso*, Patricia Cachado and Teresa GarciaAbstract
Background: Hemolytic anemia after mitral valve repair is still an underestimated complication because it is a rare
condition and there are few described case reports in the literature. The mechanism responsible for hemolysis most
commonly involves a regurgitant jet and it appears to be independent of its severity as assessed by
echocardiography. Patients may experience severe symptoms with only moderate regurgitant jets.
Case presentation: We present a case of a 74-year-old Caucasian female who developed severe hemolytic anemia
and decompensated heart failure due to a moderate mitral valve regurgitation jet, but it was not considered severe
enough to explain such hemolysis. After exclusion of other causes of hemolytic anemia and the lack of clinical and
laboratory improvement, the patient underwent valve replacement with a mechanical valve. Anemia and heart
failure symptoms gradually resolved after surgery.
Conclusion: This case report indicates the importance of including the diagnosis of hemolytic anemia after mitral
valve repair in patients with severe hemolysis and a surgical history of heart surgery, even if echocardiography
underestimates or is unclear for showing significant alterations. The interest on mitral valve repair as suggested
by the increase in the number of these procedures performed worldwide, raises the possibility that hemolytic
anemia could be probably seen more frequently in the future and be a cause of major concern, especially for
cardiac surgeons.
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A certain degree of hemolysis after heart valve surgery is
relatively common, although it may progress to severe
forms with hemolytic anemia and require transfusion
support [1]. In these cases, valve structure deterioration
or paravalvular leakage usually occurs [2]. In rare sit-
uations, hemolytic anemia can also occur in normal-
functioning prosthetic valves or even in native valves.
Mechanical trauma is the main cause of hemolysis and
the mechanism most frequently associated with hemo-
lysis is turbulence of outflow caused by a valve’s con-
figuration and/or functioning [1]. With an increasing
number of valve repairs, hemolytic anemia has been re-
ported only in a few cases [3-6].
We present a case of severe hemolytic anemia, which
was initially in doubt as an exclusive complication of
mitral valve repair, not only because it is rare, but also* Correspondence: kat_fcml@hotmail.com
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reproduction in any medium, provided the orbecause of echocardiographic findings. We also describe
the pharmacological treatment used to compensate for
the patient’s symptoms and review the literature regar-
ding this condition.
Case presentation
A 74-year-old female with known arterial hypertension,
chronic atrial fibrillation, dyslipidemia, and severe mitral
regurgitation with asymptomatic severe pulmonary hy-
pertension was diagnosed by routine echocardiography.
Mitral valve repair was performed in October 2010 with-
out apparent complications. She was discharged at day 6
post-surgery and had already complained about short-
ness of breath and bilateral leg edema. At day 18 post-
surgery, she went to the emergency department because
of worsening symptoms and she also complained of dark
urine, jaundice, and right abdominal pain. A physical
examination revealed extensive jaundice, with jugular in-
gurgitation at 45°, shortness of breath at rest, ausculta-
tion with systolic murmur audible in the precordium,l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Patient’s peripheral blood smear showing fragmented
red blood cells suggesting schistocytes.
Figure 3 Mitral plasty regurgitation.
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showed normocytic and normochromic anemia of 7 g/L,
elevated levels of transaminase, gamma-glutamyl trans-
ferase, and alkaline phosphatase, hyperbilirubinemia (18
mg/dL) with a direct fraction of 8,18, an elevated lactate
dehydrogenase level of 4467 IU/L, low haptoglobin, he-
moglobinuria, and the presence of schistocytes in a blood
smear (Figure 1) (Table 1). A thoracic X-ray revealed car-
diomegaly with pulmonary edema. Abdominal ultrasound
showed biliary sludge.
With the clinical picture of hemolytic anemia with
right heart failure and a previous heart surgery, the
patient had transthoracic echocardiography performedFigure 2 Moderate to severe mitral regurgitation (red) seen in echoca(Figure 2 and 3). We found mitral plasty with moder-
ate mitral regurgitation (Figure 2), which was unlikely
to be the cause of such severe hemolysis. The case
was discussed with cardiac surgeons, who excluded
the possibility of hemolytic anemia because of prob-
lems with mitral valve repair and advised investigation
of other etiologies that might explain the patient’s
condition.
The patient was admitted in an internal medicine ward
where she began intravenous diuretic therapy, transfu-
sion support, iron, and folate, as well as an angiotensin-
conversion enzyme blocker. Other hemolytic anemia
causes were excluded.
She was discharged after symptomatic and blood values
improved (Table 2), with a scheduled cardiothoracic
appointment and transthoracic echocardiography.
Despite her improvement, she began having the same
complaints of shortness of breath and generalized edema,
as well as abdominal discomfort, which resulted in herrdiography (parasternal view).
Table 1 Laboratory findings at first admission to the
emergency department
Hemoglobin 7,0 g/L (12–15 g/L)
Mean corpuscular volume 88 (78–96 fL)
Mean corpuscular hemoglobin 30 (27–34 pg)
Reticulocytes 10% (0,5-1,5%)
Alanine transaminase 369 U/L (5–38 U/L)
Aspartate transaminase 890 U/L (6–34 U/L)
Gammaglutamyl transferase 200 U/L (5–55 U/L)
Alkaline phosphatase 224 U/L (20–140 U/L)
Total bilirubin 18 mg/dL (0,1-1,2 mg/dL)
Direct bilirubin 8,18 mg/dL
Lactate dehydrogenase 4467 U/L (0–250 U/L)
Pro-BNP 7440 pg/mL (0–99 pg/mL)
Haptoglobin <0,01
Table 3 Recovery from anemia 1 week after valve
replacement surgery
Hemoglobin 10,2 g/L (12–15 g/L)
Mean corpuscular volume 88 (78–96 fL)
Mean corpuscular hemoglobin 30 (27–34 pg)
Reticulocytes 0,5% (0,5-1,5%)
Alanine transaminase 75 U/L (5–38 U/L)
Aspartate transaminase 80 U/L (6–34 U/L)
Lactate dehydrogenase 340 U/L (0–250 U/L)
Alkaline phosphatase 120 U/L (20–140 U/L)
Total bilirubin 2,0 mg/dL (0,1-1,2 mg/dL)
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had an Abdominal Computer Tomography Scan
performed because of her abdominal complaints and
hyperamylasemia of 1123 U/L. There was no evidence of
acute pancreatitis and the patient was discharged with the
same diagnosis of hemolytic anemia after valve repair.
One week later, there was no further improvement, and
she was re-admitted to our ward. Transthoracic echocar-
diography was similar to the first image, and despite the
same pharmacological measures, she did not improve. She
underwent another surgical procedure with mitral valve
replacement. According to the cardiac surgeon, there was
no macroscopic evidence of dysfunction in the previous
mitral valve repair.
In the post-surgery period, the patient showed signifi-
cant improvement of heart failure complaints and anemia
(Table 3). Currently, the patient is asymptomatic for acti-
vity that requires a small amount of effort, and is anicteric,
without any evidence of anemia (Table 4).
Discussion
Our skepticism for accepting the original diagnosis of
our patient was mainly because of the degree of theTable 2 Improvement of the patient after first discharge
Hemoglobin 9,3 g/L (12-15 g/L)
Mean corpuscular volume 88 (78–96 fL)
Mean corpuscular hemoglobin 30 (27–34 pg)
Reticulocytes 8% (0,5-1,5%)
Alanine transaminase 44 U/L (5–38 U/L)
Aspartate transaminase 75 U/L (6–34 U/L)
Lactate dehydrogenase 1710 U/L (0–250 U/L)
Alkaline phosphatase 121 U/L (20–140 U/L)
Total bilirubin 4,4 mg/dL (0,1-1,2 mg/dL)anemia and the lack of echocardiographic findings that
would exclusively explain such severe anemia. The cli-
nical presentation of anemia can range from a mild to a
severe form. It is well known that not all patients de-
velop hemolytic anemia, presenting with only subclinical
hemolysis with small increases in lactate dehydrogenase
levels and low haptoglobin levels [2]. Previous studies
have concluded that after mitral valve repair, minimal re-
gurgitation is often undetected by intraoperative ultra-
sound [7]. Clinical evidence of hemolytic anemia usually
manifests 90 days after surgery [7], but it may appear
sooner, depending on the presence of certain factors that
contribute to hemolysis; for example, for extracorporeal
circulation through cardiopulmonary bypass, 12% hemo-
lysis is estimated after 2 h on this mechanical system [8].
Mitral valve repair is quite effective in many cases and
may be associated with a lower long-term morbidity and
mortality than mitral valve replacement. The repair pro-
cedure includes shortening of tendinous chords, prolapsed
leaflet resection, and annuloplasty [6]. Hypothesized he-
molysis mechanisms include regurgitant jets in dehisced
annuloplasty rings, red blood cell collision on perivalvular
sutures, and residual tendinous chords [5]. These me-
chanisms delay endothelialization, maintaining hemolysis.
Some authors believe that interindividual red blood cell
fragility might play a part in hemolysis, as well as an auto-Table 4 Recovery from anemia 3 months after valve
replacement
Hemoglobin 14,2 g/L (12–15 g/L)
Mean corpuscular volume 88 (78–96 fL)
Mean corpuscular hemoglobin 30 (27–34 pg)
Reticulocytes 0,1% (0,5-1,5%)
Alanine transaminase 44 U/L (5–38 U/L)
Aspartate transaminase 47 U/L (6–34 U/L)
Lactate dehydrogenase 247 U/L (0–250 U/L)
Alkaline phosphatase 128 U/L (20–140 U/L)
Total bilirubin 0,8 mg/dL (0,1-1,2 mg/dL)
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successful treatment with corticosteroids [9].
Echocardiographic study in a case such as our patient
is an important tool because it allows investigation of
the regurgitant jet, as well as its origin. Echocardiogra-
phy, especially transesophageal echocardiography in mi-
tral regurgitation, is a sensitive and specific method [10].
Small and asymptomatic paraprosthetic jets are often
detected as a result of the high sensitivity of colour flow
mapping.
The speed, direction, and impact location should be
considered in the regurgitant jet. Distinct patterns of mi-
tral regurgitant flow disturbances have been identified in
patients with mitral prosthetic hemolysis. These include
fragmentation, collision, acceleration, deceleration, and a
free jet [7].
There are few pharmacological treatments to relieve
anemia symptoms. Beta-blockers, pentoxifylline, intra-
venous diuretics, and iron supplements might improve
symptoms [1,2]; however, they only alleviate symptoms
temporarily.
The decision to reintervene (i.e., a second surgery) is a
difficult one, in part because of the conflicting literature
concerning the significance of mild-moderate residual
regurgitation. Fix et al. found no increase in long-term
mortality in patients with mild regurgitation after repair,
although a trend for an increased late reoperation was
noted [11]. In contrast, Sheikh et al. found an increase
in postoperative morbidity and mortality in patients with
mild to moderate residual regurgitation [12].
The condition of the heart, the potential for injury
during a second cross-clamp period, and the potential
need for valve replacement with its attendant costs
should also be considered. These decisions require echo-
cardiographers with a firm and confident grasp of echo-
cardiography interpretation, surgeons with an awareness
of their capabilities, and a clear understanding by the en-
tire team of the short-term implications of reinterven-
tion and the long-term implications of residual mitral
regurgitation.
Conclusion
The purpose of this article was to describe a case of a
rare cause of hemolytic anemia, as well as to highlight
valve repair as a possible cause of hemolytic anemia.
With an increasing number of this type of procedure,
significant intravascular hemolysis is a cause of major
concern, not only for cardiac surgeons, but also for car-
diologists and internal medicine professionals, even
when the repair is considered as adequate.
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